Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Dermatologic Clinics|September 15, 2024
Exploring the Association Between Atopic Dermatitis and Malignancy: A Comprehensive Review with Therapeutic StrategiesDavid L Drum, Leo S Wan, Anika G Jallorina, et al.Immunology and Allergy Clinics of North America|July 9, 2026
Exploring the Association Between Atopic Dermatitis and Malignancy: A Comprehensive Review with Therapeutic StrategiesDavid L Drum, Leo S Wan, Anika G Jallorina, et al.Experimental Dermatology|January 10, 2025
Non-Genetic Biomarkers in Merkel Cell Carcinoma: Prognostic Implications and Predictive Utility for Response to Anti-PD-(L)1 Immune Checkpoint InhibitorsDavid L Drum, Anika G Jallorina, Leo S Wan, et al.Frontiers in Oncology|September 16, 2022
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapySjoerd P F T Nota, David O Osei-Hwedieh, David L Drum, et al.Frontiers in Oncology|August 1, 2022
Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing DisulfiramGong Zhang, Yufeng Wang, Bryan C Fuchs, et al.Frontiers in Oncology|March 6, 2026
Correction: Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiramGong Zhang, Yufeng Wang, Bryan C Fuchs, et al.Proceedings of the National Academy of Sciences of the United States of America|September 18, 2023
CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killingZheng Liu, Wenjie Liu, Wei Wang, et al.Research Square|March 3, 2023
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumorsYufeng Wang, David L Drum, Ruochuan Sun, et al.Nature Communications|September 15, 2023
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironmentYufeng Wang, David L Drum, Ruochuan Sun, et al.Pageof 1